(Q44531873)

3 December 2017

A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile spasms (English)

1 reference

3 December 2017

14

Maryse Lassonde

1 reference

3 December 2017

15

Lionel Carmant

1 reference

3 December 2017

Jonathan Y Bitton

1

1 reference

3 December 2017

Hannelore C Sauerwein

2

1 reference

3 December 2017

Shelly K Weiss

3

1 reference

3 December 2017

Elizabeth J Donner

4

1 reference

3 December 2017

Sharon Whiting

5

1 reference

3 December 2017

Joseph M Dooley

6

1 reference

3 December 2017

Carter Snead

7

1 reference

3 December 2017

Kevin Farrell

8

1 reference

3 December 2017

Elaine C Wirrell

9

1 reference

3 December 2017

Ismail S Mohamed

10

1 reference

3 December 2017

Gabriel M Ronen

11

1 reference

3 December 2017

Milagros Salas-Prato

12

1 reference

3 December 2017

Devendra Amre

13

1 reference

3 December 2017

13 August 2012

1 reference

3 December 2017

1 reference

3 December 2017

53

1 reference

3 December 2017

9

1 reference

3 December 2017

1570-1576

1 reference

Isradipine antagonizes hypobaric hypoxia induced CA1 damage and memory impairment: Complementary roles of L-type calcium channel and NMDA receptors

3 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Infantile spasms: West syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Glutamate neurotoxicity and diseases of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Infantile spasms: diagnosis and assessment of treatment response by video-EEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Is hypsarrhythmia a form of non-convulsive status epilepticus in infants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Effects of nimodipine on the behavioral sequalae of experimental status epilepticus in prepubescent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

The treatment and management of alternating hemiplegia of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Ca++ and Na+ channels involved in neuronal cell death. Protection by flunarizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Favourable prognostic factors with infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

High-dose vitamin B(6) treatment in West syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

L-type voltage-gated Ca2+ channels: a single molecular switch for long-term potentiation/long-term depression-like plasticity and activity-dependent metaplasticity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03623.X

10.1111/J.1528-1167.2012.03623.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference